Aaron is the Chief Strategy Officer at Adimab, with over 25 years of experience in biotechnology, focusing on discovering and developing novel first-in-class antibody therapeutics. Before joining Adimab, Aaron served as the Chief Scientific Officer of Twist Bioscience, where he led their Biopharma Solutions business. Prior to Twist, he served as Chief Scientific Officer of LakePharma, leading the California Antibody Center. He is the author of over 40 peer-reviewed papers and 70 issued patents in the antibody space.